S100A7's Role in Breast Cancer and Osteoclast Formation
Author Information
Author(s): Paruchuri Vikram, Prasad Anil, McHugh Kevin, Bhat Hari K., Polyak Kornelia, Ganju Ramesh K.
Primary Institution: Beth Israel Deaconess Medical Center, Harvard Medical School
Hypothesis
S100A7 regulates EGF-induced signaling and osteoclast formation in breast cancer cells.
Conclusion
Downregulation of S100A7 inhibits EGF-induced signaling, reduces angiogenesis, and decreases osteoclast formation in breast cancer.
Supporting Evidence
- S100A7 expression was increased by EGF in breast cancer cell lines.
- S100A7-downregulated cells showed reduced EGF-induced migration and invasion.
- Downregulation of S100A7 led to decreased angiogenesis in vivo.
- S100A7-downregulated cells had fewer osteoclasts and less IL-8 expression.
Takeaway
S100A7 is a protein that helps breast cancer cells grow and spread, and when it's turned down, the cancer cells don't grow as much and don't cause as many problems in the bones.
Methodology
The study involved cell culture experiments with MCF-7 and MDA-MB-468 breast cancer cell lines, assessing EGF-induced signaling, migration, invasion, and osteoclast formation.
Potential Biases
Potential bias in the selection of cell lines and experimental conditions.
Limitations
The study primarily used in vitro models and may not fully represent in vivo conditions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website